Crossmark

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.01.002

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Aomar-Millán, Ismael F.

Fatoul-del Pino, Geoorgette

Torres-Parejo, Úrsula

Pérez Fernández, Laura

Martínez-Diz, Silvia

Salvatierra, Juan
License Information

Text and Data Mining valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.01.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2022.06.015

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.